SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 53 filers reported holding SQZ BIOTECHNOLOGIES CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $342 | -85.7% | 1,268 | -70.2% | 0.00% | – |
| Q1 2023 | $2,386 | -77.4% | 4,261 | -70.1% | 0.00% | – |
| Q4 2022 | $10,557 | -79.3% | 14,267 | -37.0% | 0.00% | – |
| Q3 2022 | $51,000 | -29.2% | 22,636 | +0.1% | 0.00% | – |
| Q2 2022 | $72,000 | -51.7% | 22,604 | -27.0% | 0.00% | – |
| Q1 2022 | $149,000 | -55.5% | 30,974 | -17.5% | 0.00% | – |
| Q4 2021 | $335,000 | -28.6% | 37,542 | +15.5% | 0.00% | – |
| Q3 2021 | $469,000 | -5.1% | 32,513 | -4.8% | 0.00% | – |
| Q2 2021 | $494,000 | +26.3% | 34,164 | +19.6% | 0.00% | – |
| Q1 2021 | $391,000 | +354.7% | 28,558 | +869.7% | 0.00% | – |
| Q4 2020 | $86,000 | – | 2,945 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGER MANAGEMENT, LLC | 807,827 | $23,411,000 | 1.79% |
| Alphabet Inc. | 831,389 | $24,094,000 | 1.16% |
| Artal Group S.A. | 1,606,308 | $46,551,000 | 1.00% |
| 683 Capital Management, LLC | 466,176 | $13,510,000 | 0.64% |
| MAVERICK CAPITAL LTD | 935,971 | $27,124,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 2,513,924 | $72,854,000 | 0.31% |
| CAAS CAPITAL MANAGEMENT LP | 150,000 | $4,347,000 | 0.04% |
| HRT FINANCIAL LP | 17,456 | $505,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 11,660 | $350,000 | 0.01% |
| Hudock, Inc. | 350 | $10,000 | 0.00% |